Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema (PREVENT)

NACompletedINTERVENTIONAL
Enrollment

1,201

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Lymphedema
Interventions
DEVICE

23-32 mmHg compression sleeve with gauntlet

A compression intervention consisting of a sleeve and gauntlet with 23-32mm of tension worn for four weeks that is initiated based on a BIS L-Dex change that is ≥6.5 units higher than pre-surgical baseline measure, or a tape measurement guided volume change in the affected arm that is between ≥5% and \<10% above pre-surgical baseline.

Trial Locations (10)

2109

Macquarie University, Sydney

10032

New York Presbyterian - University Hospital of Columbia and Cornell, New York

15212

Allegheny Health Research Institute, Pittsburgh

23298

Massey Cancer Center, Richmond

32224

Mayo Clinic, Jacksonville

37240

Vanderbilt University, Nashville

63703

Southeast Health, Cape Girardeau

66160

University of Kansas Medical Center, Kansas City

77030

The University of Texas MD Anderson Cancer Center, Houston

40202-1798

University of Louisville, Louisville

All Listed Sponsors
collaborator

Vanderbilt University

OTHER

collaborator

Macquarie University, Australia

OTHER

lead

ImpediMed Limited

INDUSTRY

NCT02167659 - Bioimpedance Spectroscopy Versus Tape Measure in Prevention of Lymphedema (PREVENT) | Biotech Hunter | Biotech Hunter